Target intelligence / Profile preview

Nutrient signaling pathways

Molecular classification
Signaling pathway, Metabolic regulator
01

Overview

Nutrient signaling pathways are integrated networks of biochemical cascades that allow cells to sense and adapt to changes in the availability of energy and macronutrients like glucose, amino acids, and lipids (Efeyan et al., 2015, Nature). These pathways include key molecular sensors such as the mechanistic target of rapamycin (mTOR), which promotes anabolic processes during nutrient abundance, and AMP-activated protein kinase (AMPK), which triggers catabolic energy-producing processes during scarcity (Saxton & Sabatini, 2017, Cell; Hardie et al., 2012, Nat Rev Mol Cell Biol). Other critical components include sirtuins and the insulin/IGF-1 signaling axis, which coordinate cellular metabolism with systemic energy status (Imai & Guarente, 2014, Trends Cell Biol). Dysregulation of these pathways is a central driver in the development of metabolic syndrome, type 2 diabetes, obesity, and various cancers where nutrient sensing is hijacked to support uncontrolled proliferation (González & Hall, 2017, EMBO Mol Med). Therapeutic strategies often involve small molecules that modulate specific nodes within these pathways, such as metformin for AMPK activation or rapalogs for mTOR inhibition, to restore metabolic balance or suppress tumor growth. However, targeting these fundamental pathways presents challenges due to their ubiquitous role in normal physiology, potentially leading to side effects like immunosuppression or metabolic instability.

Other names
Nutrient sensing pathwaysMetabolic signaling pathwaysNutrient-response pathways
02

Mechanism of action

Modulation of intracellular metabolic sensors (e.g., AMPK activation, mTOR inhibition) and hormonal receptors (e.g., Insulin receptor) to regulate energy homeostasis and cellular growth.

03

Biological functions

Metabolism regulationCell growthAutophagyHomeostasisCell proliferation
04

Disease associations

Type 2 diabetesObesityCancerNeurodegenerative diseaseAging-related disease
05

Safety considerations

Metabolic dysregulationImmunosuppressionHypoglycemiaGastrointestinal toxicityGrowth inhibition in non-target tissues
06

Interacting drugs

Metformin

5 more in the full profile.

07

Biomarkers

Blood glucoseHemoglobin A1c (HbA1c)Phosphorylated S6 Kinase 1 (p-S6K1)Phosphorylated AMPK (p-AMPK)Insulin-like growth factor 1 (IGF-1)

Beyond the preview

Go deeper on Nutrient signaling pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nutrient signaling pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call